Get started
Author

Antonino Carlo Privitera

Observed names: A C Privitera, A.C. Privitera, Antonino C. Privitera
Institution: Ospedale Cannizzaro
ORCID: 0000-0002-8978-1661
Observed ORCID: 0000-0002-8978-1661
OpenAlex ID: A5102776826
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis – Definition, Clinical Presentation and Diagnosis
2024 · Nicola de Bortoli, Pierfrancesco Visaggi, et al. · Digestive and Liver Disease · 71
PDF
The 1st EoETALY Consensus on the Diagnosis and Management of Eosinophilic Esophagitis–Current Treatment and Monitoring
2024 · Nicola de Bortoli, Pierfrancesco Visaggi, et al. · Digestive and Liver Disease · 68
PDF
The SPOSIB SB2 Sicilian Cohort: Safety and Effectiveness of Infliximab Biosimilar SB2 in Inflammatory Bowel Diseases, Including Multiple Switches
2020 · Fabio Salvatore Macaluso, Walter Fries, et al. · Inflammatory Bowel Diseases · 50
The real-world effectiveness of vedolizumab on intestinal and articular outcomes in inflammatory bowel diseases
2018 · Fabio Salvatore Macaluso, Rosalba Orlando, et al. · Digestive and Liver Disease · 45
Persistence on Anti-Tumour Necrosis Factor Therapy in Older Patients with Inflammatory Bowel Disease Compared with Younger Patients: Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
2020 · the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD), Serena Porcari, et al. · Drugs & Aging · 29
SPOSAB ABP 501: A Sicilian Prospective Observational Study of Patients with Inflammatory Bowel Disease Treated with Adalimumab Biosimilar ABP 501
2021 · Fabio Salvatore Macaluso, Maria Cappello, et al. · Journal of Gastroenterology and Hepatology · 24
A propensity score weighted comparison of vedolizumab and adalimumab in Crohn's disease
2020 · Fabio Salvatore Macaluso, Marco Ventimiglia, et al. · Journal of Gastroenterology and Hepatology · 23
PDF
Late-onset Crohn’s disease: a comparison of disease behaviour and therapy with younger adult patients: the Italian Group for the Study of Inflammatory Bowel Disease ‘AGED’ study
2019 · Anna Viola, Rita Monterubbianesi, et al. · European Journal of Gastroenterology & Hepatology · 23
A real life comparison of the effectiveness of adalimumab and golimumab in moderate-to-severe ulcerative colitis, supported by propensity score analysis
2018 · Sara Renna, Filippo Mocciaro, et al. · Digestive and Liver Disease · 20
Activities related to inflammatory bowel disease management during and after the coronavirus disease 2019 lockdown in Italy: How to maintain standards of care
2020 · Simone Saibeni, Ludovica Scucchi, et al. · United European Gastroenterology Journal · 17
PDF
Effectiveness of Ustekinumab on Crohn‘s Disease Associated Spondyloarthropathy: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
2020 · Fabio Salvatore Macaluso, Walter Fries, et al. · Expert Opinion on Biological Therapy · 15
Real-Life Effectiveness and Safety of Golimumab and Its Predictors of Response in Patients with Ulcerative Colitis
2019 · Fabrizio Bossa, Giuseppe Biscaglia, et al. · Digestive Diseases and Sciences · 15
Two‐year effectiveness and safety of golimumab in ulcerative colitis: An IG‐IBD study
2020 · Daniela Pugliese, Giuseppe Privitera, et al. · United European Gastroenterology Journal · 14
PDF
Telemedicine and Remote Screening for COVID-19 in Inflammatory Bowel Disease Patients: Results From the SoCOVID-19 Survey
2020 · Massimo Caludio Fantini, Livia Biancone, et al. · Inflammatory Bowel Diseases · 8
PDF
Prevalence of Endoscopic and Histological Lesions at Upper Endoscopy: A Cross-Sectional, Multicentre Study in Clinical Practice
2024 · Vincenzo De Francesco, Angelo Zullo, et al. · GE Portuguese Journal of Gastroenterology · 6
Suboptimal disease control and contributing factors in Italian IBD patients: The IBD-PODCAST Study
2024 · Emma Calabrese, Sara Onali, et al. · Digestive and Liver Disease · 4
The effectiveness of ustekinumab and vedolizumab as third-line biologic therapy in patients with Crohn's disease
2022 · Fabio Salvatore Macaluso, Mauro Grova, et al. · Digestive and Liver Disease · 4
Parastomal hernia repair with the use of Parietex composite mesh: a technical note.
2009 · Lino Succi, Nnawuihe Luca Ohazuruike, et al. · PubMed · 3
P305 Effectiveness and Safety of Vedolizumab in Biologic-Naïve Patients: Real-World Data from the Sicilian Network for Inflammatory Bowel Diseases (SN-IBD)
2021 · F Macaluso, W Fries, et al. · Journal of Crohn s and Colitis · 2
P762 GO-CARE: A prospective multi-centre observational study of golimumab effectiveness and quality of life in a real-life UC patient population in Italy
2018 · A Armuzzi, S Marchi, et al. · Journal of Crohn s and Colitis · 2
685 Risk Factor Analysis for Therapy Related Adverse Events and Infections in Elder Patients With Inflammatory Bowel Disease; An Analysis From the iG-IBD Aged Study
2015 · Walter Fries, Anna Viola, et al. · Gastroenterology · 2
Biofeedback therapy for outlet dysfunction: our experience.
2009 · Antonino Carlo Privitera, Conchita Emanuela Oliveri, et al. · PubMed · 2
Biofeedback therapy for faecal incontinence: our experience.
2009 · Antonino Carlo Privitera, Conchita Emanuela Oliveri, et al. · PubMed · 2
Comparative effectiveness and safety of tofacitinib and filgotinib in patients with ulcerative colitis: A propensity score-weighted cohort study
2025 · Fabio Salvatore Macaluso, Walter Fries, et al. · Digestive and Liver Disease · 1
STW 5-II for Treatment of Functional Gastrointestinal Disorders: Mechanism and Clinical Efficacy
2025 · Antonio Tursi, Beatrice Marinoni, et al. · Digestive Diseases · 1
Works count: 34
Citation count: 456
H-index: 13
I10-index: 13
Year
Topic
Type